By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Strativa Pharmaceuticals 

300 Tice Boulevard

Woodcliff Lake  New Jersey  07677  U.S.A.
Phone: 201-802-4200 Fax: n/a



Company News
FDA Green Lights Strativa Pharmaceuticals' Nascobal® (Cyanocobalamin, USP) Nasal Spray Single-Use Device 6/11/2014 6:20:05 AM
John A. MacPhee Resigns From Strativa Pharmaceuticals 12/17/2010 10:32:24 AM
Strativa Pharmaceuticals Signs Agreement With Swedish Orphan Biovitrum Regarding Nascobal(R) 10/26/2010 7:20:08 AM
BioAlliance Pharma Announces the Launch of Oravig(R) on the US Market by Its Commercial Partner, Strativa Pharmaceuticals/Par Pharmaceutical, Inc. 8/24/2010 10:36:31 AM
FDA Approves Strativa Pharmaceuticals' Zuplenz(R) (ondansetron) Oral Soluble Film 7/6/2010 7:15:16 AM
FDA Approves Strativa Pharmaceuticals's Oravig(TM) Buccal Tablets for Treatment of Oropharyngeal Candidiasis 4/16/2010 11:35:39 AM
Strativa Pharmaceuticals Says FDA Declines Nausea Drug Approval; FDA Citing Travel Restrictions to India 2/8/2010 6:35:13 AM
MonoSolRx LLC and Strativa Pharmaceuticals Extend Strategic Relationship 1/5/2010 10:33:14 AM
Strativa Pharmaceuticals' Development Partner, BioAlliance Pharma, Presents Phase III Study 9/15/2009 8:06:30 AM
Strativa Pharmaceuticals's Development Partner, BioAlliance Pharma, Submits Loramyc(R) NDA 6/16/2009 9:01:35 AM